General Information of Drug (ID: DMSW0HB)

Drug Name
PMID26651364-Compound-5g Drug Info
Indication
Disease Entry ICD 11 Status REF
Crohn disease DD70 Patented [1]
Ulcerative colitis DD71 Patented [1]
Urinary tract infection GC08 Patented [1]
Cross-matching ID
TTD Drug ID
DMSW0HB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
EB8018 DM753H8 Crohn disease DD70 Phase 2 [2]
GSK3882347 DM1DU20 Urinary tract infection GC08 Phase 1 [3]
GSK3882347 DM1DU20 Urinary tract infection GC08 Phase 1 [4]
Biaryl mannoside derivative 24 DMF5TB4 Crohn disease DD70 Patented [1]
PMID26651364-Compound-5 DMH7XL3 Crohn disease DD70 Patented [1]
PMID26651364-Compound-116 DMJ3201 Crohn disease DD70 Patented [1]
Biaryl mannoside derivative 8 DMWF2VG Crohn disease DD70 Patented [1]
Beta-cyclodextrin conjugate derivative 3 DMQJF4P Crohn disease DD70 Patented [1]
PMID26651364-Compound-109 DM01IWV Crohn disease DD70 Patented [1]
PMID26651364-Compound-114 DM5GHJA Crohn disease DD70 Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Fimbrin D-mannose adhesin (Bact FimH) TTTCRU2 FIMH_ECOLI Antagonist [1]

References

1 Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease.Expert Opin Ther Pat. 2016;26(2):175-97.
2 Clinical pipeline report, company report or official report of Enterome Biosciences.
3 Clinical pipeline report, company report or official report of Fimbrion Therapeutics
4 Clinical pipeline report, company report or official report of GlaxoSmithKline